Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods and kits for linking polymorphic sequences to expanded repeat mutations

a polymorphic sequence and expanded repeat technology, applied in the field of methods and kits for linking polymorphic sequences to expanded repeat mutations, can solve the problems of not disclosing the use of reverse transcription, unfavorable patient safety, and high care cos

Pending Publication Date: 2012-07-05
MEDTRONIC INC
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes a kit for diagnosing and treating Huntington's disease by targeting specific SNPs. The kit includes two sets of allele-specific RT-PCR primers that can selectively hybridize to different variants of specific SNPs. The kit can also include an allele-specific therapy, such as a short RNA molecule or a nucleic acid construct encoding it. The technical effect of this invention is the development of a reliable and effective tool for identifying and treating Huntington's disease.

Problems solved by technology

The combination of emotional, cognitive and motor symptoms in HD contributes to an unusually high cost of care.
U.S. Patent Application Publication No. 20030039964 describes a method for isolation of one sequence in a mixture by hybridization to a fixed probe, but does not disclose the use of reverse transcription.
U.S. Pat. No. 6,013,431 describes a method for analysis of bases adjacent to a hybridized, immobilized oligo, but does not disclose enrichment of one allele over the other.
WO Patent Application No. 9820166 describes a method for specific selection of one allele over the other, followed by mass spectroscopic analysis of the selected molecule, but does not disclose the use of reverse transcription.
None of these references disclose methods and diagnostic kits for linking polymorphic sequences to expanded repeat mutations for improved allele-specific diagnosis.
U.S. Patent Publication No. 20060270623 (McSwiggen) discloses multiple siRNA sequences, including those comprising SNP variants, but does not provide any working examples regarding allele-specific RNA interference using these disclosed siRNA sequences, nor disclose how to determine which allele-specific siRNA to administer to a particular Huntington's disease human patient in order to effectively treat that patient's disease by suppression of only the expanded Huntington allele in that patient.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and kits for linking polymorphic sequences to expanded repeat mutations
  • Methods and kits for linking polymorphic sequences to expanded repeat mutations
  • Methods and kits for linking polymorphic sequences to expanded repeat mutations

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0111]RNA-Isolation and Reverse Transcription Reaction.

[0112]Applicants analyzed the CAG-repeat sequences in the Huntington's disease gene in the mRNA obtained from a patient's cells using the following allele-specific reverse transcription reaction. The subject SNP sites in the Huntington's disease gene (IT15) are designated using the identification number provided by the National Center for Biotechnology Information (NCBI) database, accessible at: http: / / www.ncbi.nlm.nih.gov / entrez / query.fcgi?db=snp.

[0113]Development of Allele-Specific Reverse Transcription.

[0114]Donor-1 (a Caucasian female who was 28 years old at the time of cell collection and whose mother was diagnosed with HD at the age 49) was determined to be heterozygous (adenine versus cytosine) at SNP site rs363125. In order to design an allele-specific RNA interference-based therapy for donor-1, it is necessary to determine which of these SNP sequences is associated with the expanded CAG repeat mutation that is located a...

example 2

[0119]Development of SNP-Specific Real Time PCR Assays.

[0120]To be able to verify that allele-specific suppression of HD mRNA is occurring in cells, it is necessary to be able to quantify the amount of HD mRNA corresponding to each allele individually. Molecular beacons are synthetic oligonucleotide probes that have a fluorophore and a quencher covalently linked to the respective ends of the oligo. In solution, the beacon adopts a hairpin conformation, causing the fluorophore to be quenched. However, upon hybridization with complementary DNA in a PCR reaction, the hairpin conformation is lost and fluorescence from the fluorophore can be detected. Beacons can be constructed such that as little as a single nucleotide mismatch between the beacon and the complementary DNA is sufficient for the probe to be more stable in its self-annealed state than in the probe-cDNA hybrid. The inventors designed two such beacons corresponding to the two allelic variants of SNP rs363125, for the A allel...

example 3

[0122]Allele-Specific Suppression of Huntingtin mRNA.

[0123]In one set of experiments, fibroblasts were cultured in 25 cm2 culture flasks (Nunc) as described, but without the addition of PSN antibiotics and Fungizone. Lipofectamine 2000 (Invitrogen) was used to conduct siRNA transfection at three different conditions: 1) mock transfection (n=8); 2) transfection with scrambled siRNA (Ambion) (n=4); and 3) transfection with siRNA sequence 5′-GAAGUACUGUCCCCAUCUCdTdT-3′, SEQ ID NO: 228 and its complementary strand SEQ ID NO: 229, (Ambion) (n=7) at a concentration of 100 nM. This siRNA has a guanine located at position 16 relative to the 3′ end of the complementary region of the target huntingtin mRNA, providing specificity for the allele containing cytosine at the SNP position. A parallel cell culture was transfected with a fluorescently labeled Block-It siRNA (Invitrogen) to verify efficiency of Lipofectamine 2000 transfection. The cells were incubated overnight at 37° C., 5% CO2 and ma...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
humidityaaaaaaaaaa
critical lengthaaaaaaaaaa
sizeaaaaaaaaaa
Login to View More

Abstract

Methods and kits are provided for determining which single nucleotide polymorphism (“SNP”) variant of an allele of a heterozygous patient is on the same allele as a disease-causing mutation. Also, provided are kits for multi-SNP diagnosis and treatment, targeting combinations of SNPs having greater joint prevalence of heterozygosity in Huntington's population than individual SNPs considered individually.

Description

FIELD OF THE INVENTION[0001]The present invention relates generally to compositions and methods for diagnosing diseases which have an allele-specific therapy and a disease-causing mutation that is sufficiently distant from the molecular site of the therapy to require a diagnostic linking method.BACKGROUND OF THE INVENTION[0002]Expansions of CAG trinucleotide repeats (CAG repeats) in coding regions of human genes cause numerous disorders by generating proteins with elongated polyglutamine (polyQ) stretches. This group of disorders includes by way of example spinocerebellar ataxia type 1, spinocerebellar ataxia type 2, spinocerebellar ataxia type 3, spinocerebellar ataxia type 6, spinocerebellar ataxia type 7, spinocerebellar ataxia type 17, spinal and bulbar muscular atrophy, Huntington's disease, and dentatorubral-pallidoluysian atrophy. (Wanker E. E. (2000) Biol. Chem., 381:937-942; Gusella J. F. and MacDonald, M. E. (2000) Nature Rev. Neurosci., 1:109-115; and Usdin K. and Grabczy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/713A61P25/00A61P25/14C12Q1/68
CPCC12Q1/6809C12Q1/6827C12Q1/6883C12Q2600/158C12Q2600/156C12Q2537/143C12Q2535/125C12Q2521/107A61P25/00A61P25/14C12N15/113C12N2310/14C12N2320/34
Inventor VAN BILSEN, PAULBURRIGHT, ERIC N.KAEMMERER, WILLIAM F.JASPERS, LEONIELOMBARDI, MARIA STELLA
Owner MEDTRONIC INC